Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.05B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.61B |
| 3 |
Tesla
TSLA
|
+$636M |
| 4 |
TSMC
TSM
|
+$604M |
| 5 |
iShares Bitcoin Trust
IBIT
|
+$330M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.25B |
| 2 |
Apple
AAPL
|
+$1.13B |
| 3 |
Microsoft
MSFT
|
+$988M |
| 4 |
Meta Platforms (Facebook)
META
|
+$572M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$570M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 1.55% |
| 2 | Consumer Discretionary | 0.95% |
| 3 | Financials | 0.77% |
| 4 | Healthcare | 0.67% |
| 5 | Industrials | 0.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
CALL
Axsome Therapeutics
AXSM
$10.8B
| $35.5M | 0.01% |
304,300
-43,600
| -13% | -$4.97M |
|
1252
PUT
VanEck Junior Gold Miners ETF
GDXJ
$10B
| $35.5M | 0.01% |
620,000
-593,500
| -49% | -$29.9M |
|
1253
United States Oil Fund
USO
$1.97B
| $35.4M | 0.01% |
458,054
+291,259
| +175% | +$22.2M |
|
1254
CALL
Keurig Dr Pepper
KDP
$43.3B
| $35.4M | 0.01% |
1,034,000
-242,900
| -19% | -$7.89M |
|
1255
PUT
Ross Stores
ROST
$77.4B
| $35.2M | 0.01% |
275,400
-654,800
| -70% | -$91.6M |
|
1256
Moderna
MRNA
$63.4B
| $34.8M | 0.01% |
1,228,711
-894,997
| -42% | -$31.8M |
|
1257
CALL
Vanguard Morningstar Growth ETF
VUG
$225B
| $34.8M | 0.01% |
563,400
-344,400
| -38% | -$23.2M |
|
1258
PUT
Fidelity National Information Services
FIS
$20.9B
| $34.8M | 0.01% |
466,100
+294,900
| +172% | +$22.2M |
|
1259
Marriott International
MAR
$93.3B
| $34.8M | 0.01% |
146,106
-21,495
| -13% | -$5.84M |
|
1260
Las Vegas Sands
LVS
$30.6B
| $34.7M | 0.01% |
899,466
+594,673
| +195% | +$26.3M |
|
1261
PUT
Schwab US Dividend Equity ETF
SCHD
$112B
| $34.7M | 0.01% |
1,241,300
-145,900
| -11% | -$4.07M |
|
1262
PUT
Cenovus Energy
CVE
$56.7B
| $34.7M | 0.01% |
2,493,400
+976,100
| +64% | +$14.1M |
|
|
ITCI
1263
PUT
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $34.7M | 0.01% |
262,900
+220,400
| +519% | +$27.5M |
|
1264
PUT
Edison International
EIX
$28.8B
| $34.7M | 0.01% |
588,600
+366,300
| +165% | +$21.1M |
|
1265
CALL
NetApp
NTAP
$36.8B
| $34.6M | 0.01% |
394,400
+89,600
| +29% | +$9.91M |
|
1266
CALL
UiPath
PATH
$8.63B
| $34.6M | 0.01% |
3,362,600
+1,158,700
| +53% | +$14.9M |
|
1267
Vanguard Morningstar Small-Cap ETF
VB
$81.9B
| $34.6M | 0.01% |
156,114
+151,130
| +3,032% | +$36.1M |
|
1268
CALL
Ally Financial
ALLY
$13B
| $34.6M | 0.01% |
948,200
-153,900
| -14% | -$5.67M |
|
1269
NXP Semiconductors
NXPI
$56.7B
| $34.6M | 0.01% |
181,946
+13,646
| +8% | +$2.91M |
|
1270
CALL
HP
HPQ
$27B
| $34.6M | 0.01% |
1,248,400
-902,200
| -42% | -$28.5M |
|
1271
FTAI Aviation
FTAI
$20.6B
| $34.5M | 0.01% |
310,716
+75,035
| +32% | +$8.87M |
|
1272
CALL
Antero Resources
AR
$11.7B
| $34.4M | 0.01% |
851,800
-505,300
| -37% | -$19.4M |
|
1273
PUT
Insmed
INSM
$27.1B
| $34.4M | 0.01% |
451,400
+103,800
| +30% | +$7.94M |
|
1274
PUT
AGNC Investment
AGNC
$12.9B
| $34.3M | 0.01% |
3,579,400
-358,200
| -9% | -$3.58M |
|
1275
CALL
CMS Energy
CMS
$21.6B
| $34.3M | 0.01% |
+456,500
| New | +$31.9M |
|
Similar funds
Jeff Yass's Q1 2025 Portfolio in Review
As of Q1 2025, Jeff Yass held 13,842 positions worth $586B, down 12% from $663B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jeff Yass withdrew a net $24.4B in Q1 2025, closing 1,482 positions and reducing 4,842 holdings. Its most notable exit was Inari Medical, Inc. Common Stock, an estimated $24M position sold in full.
By sector, the portfolio is most concentrated in Technology at 1.6% of assets, down from 2% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Jeff Yass opened a new position in Brookfield Asset Management worth $86M.
- Jeff Yass's largest Q1 2025 buy was Brookfield Asset Management: 1,775,684 shares worth $86M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $4.05B increase.
- Jeff Yass's biggest Q1 2025 reduction was Invesco QQQ Trust, cutting an estimated $1.25B.
- Jeff Yass fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $24M.
- Jeff Yass's ten largest holdings make up 28% of its $586B portfolio in Q1 2025.
- Jeff Yass opened 1,775 new positions and closed 1,482 in Q1 2025.
- Jeff Yass's portfolio value fell 12% quarter-over-quarter to $586B.
Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.